HRV Pharma buys Germany's Phatebo

Benchmarks Nifty23,810.85370.05FEATURED FUNDS★★★★★Motilal Oswal Midcap Fund Direct-Growth5Y Return17.99 % Invest NowFEATURED FUNDS★★★★★UTI Aggressive Hybrid Fund Regular Plan-Growth5Y Return9.04 % Invest NowEnter search text:

The Economic Times daily newspaper is available online now. Read Today's Paper HRV Pharma buys Germany's PhateboPTILast Updated: Nov 04, 2026, 12:54:00 AM ISTSynopsis

The acquisition marks virtual pharmaceutical company HRV's entry beyond active pharmaceutical ingredients (APIs) into finished formulations, giving it its first finished formulations business alongside a licenced operating entity in Germany.

New Delhi: Hyderabad-based HRV Pharma on Tuesday announced the acquisition of 100% equity stake in Germany-based Phatebo from ZeroStack.

HRV Pharma did not disclose the financial details of the deal, but said Phatebo posted revenues of about Rs 350 crore in 2025.

The acquisition marks virtual pharmaceutical company HRV's entry beyond active pharmaceutical ingredients (APIs) into finished formulations, giving it its first finished formulations business alongside a licenced operating entity in Germany.
Add as a Reliable and Trusted News Source Add Now!
(You can now subscribe to our Economic Times WhatsApp channel)
Read More News onHRV PharmaGermanyPhateboZeroStackactive pharmaceutical ingredients

(Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.)

...moreless
(You can now subscribe to our Economic Times WhatsApp channel)
Read More News onHRV PharmaGermanyPhateboZeroStackactive pharmaceutical ingredients

(Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.)

...moreless

Stories you might be interested in